Literature DB >> 3609497

In vitro autoregulation of glucose utilization in rat soleus muscle.

S Sasson, D Edelson, E Cerasi.   

Abstract

The possibility that glucose may directly regulate its rate of utilization in skeletal muscle was investigated in vitro with the rat soleus muscle. Preincubation of the muscles with varying glucose concentrations modulated the rate of glucose utilization through the glycolytic pathway during a subsequent incubation. At glucose concentrations below approximately 3.0 mM, utilization was maximal (26.8 +/- 2.4 and 87.5 +/- 4.8 nmol X g-1 X min-1 when assayed in the presence of 0.5 and 5.0 mM glucose, respectively). Preincubation with higher glucose concentrations (up to 20 mM) reduced the utilization by 40-60% in a biphasic manner: a rapid fall between 1 and 4 mM, followed by a gradual approximately 2% decrease per each millimolar increase of glucose. The effect of preexposure to glucose was not due to substrate dilution by the remaining glucose in the extracellular or intracellular space of the muscle. The uptake of the nonmetabolizable glucose analogues 3-O-methylglucose and 2-deoxyglucose was also modulated by extracellular glucose in a similar manner. Thus, the regulatory site seems to reside in the transport function of the hexose. The ATP content was very similar in muscles preexposed to 1.0 and 15.0 mM glucose for 3 h and therefore does not seem to be the mediator of the glucose effect. This substrate regulation of the rate of glucose transport and of the glycolytic flux may be operative in the in vivo glucose homeostatic system and may contribute to the reduced peripheral glucose utilization observed in diabetes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3609497     DOI: 10.2337/diab.36.9.1041

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Hexose specificity for downregulation of HepG2/brain-type glucose transporter gene expression in L6 myocytes.

Authors:  F Maher; L C Harrison
Journal:  Diabetologia       Date:  1990-11       Impact factor: 10.122

2.  The effects of amylin on carbohydrate metabolism in skeletal muscle in vitro and in vivo.

Authors:  B Leighton; E Foot
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

3.  K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 years.

Authors:  M Alvarsson; A Wajngot; E Cerasi; S Efendic
Journal:  Diabetologia       Date:  2005-09-14       Impact factor: 10.122

4.  Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects.

Authors:  T P Ciaraldi; L Abrams; S Nikoulina; S Mudaliar; R R Henry
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

5.  Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.

Authors:  R C Bonadonna; S Del Prato; M P Saccomani; E Bonora; G Gulli; E Ferrannini; D Bier; C Cobelli; R A DeFronzo
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Glucose regulates its transport in L8 myocytes by modulating cellular trafficking of the transporter GLUT-1.

Authors:  R Greco-Perotto; E Wertheimer; B Jeanrenaud; E Cerasi; S Sasson
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

7.  Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance.

Authors:  J R Zierath; D Galuska; L A Nolte; A Thörne; J S Kristensen; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

8.  Glucose-induced insulin resistance of skeletal-muscle glucose transport and uptake.

Authors:  E A Richter; B F Hansen; S A Hansen
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

9.  Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus.

Authors:  D L Rothman; I Magnusson; G Cline; D Gerard; C R Kahn; R G Shulman; G I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

10.  Antihyperglycaemic activity of 2,4:3,5-dibenzylidene-D-xylose-diethyl dithioacetal in diabetic mice.

Authors:  Arie Gruzman; Anna Elgart; Olga Viskind; Hana Billauer; Sharon Dotan; Guy Cohen; Eyal Mishani; Amnon Hoffman; Erol Cerasi; Shlomo Sasson
Journal:  J Cell Mol Med       Date:  2012-03       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.